| 1 |
34229013 | Neuroinflammation and L-dopa-induced abnormal involuntary movements in 6-hydroxydopamine-lesioned rat model of Parkinson's disease are counteracted by combined administration of a 5-HT1A/1B receptor agonist and A2A receptor antagonist. | 2021 Sep 15 |
4 |
| 2 |
33050305 | The Multimodal Serotonergic Agent Vilazodone Inhibits L-DOPA-Induced Gene Regulation in Striatal Projection Neurons and Associated Dyskinesia in an Animal Model of Parkinson's Disease. | 2020 Oct 9 |
1 |
| 3 |
25442003 | Inhibiting Lateral Habenula Improves L-DOPA-Induced Dyskinesia. | 2016 Mar 1 |
2 |
| 4 |
26871939 | Antidyskinetic effect of A2A and 5HT1A/1B receptor ligands in two animal models of Parkinson's disease. | 2016 Apr |
3 |
| 5 |
21507338 | Differential expression of FosB, c-Fos, and Zif268 in forebrain regions after acute or chronic L-DOPA treatment in a rat model of Parkinson's disease. | 2011 Jun 1 |
2 |
| 6 |
18583175 | Direct and indirect striatal efferent pathways are differentially influenced by low and high dyskinetic drugs: behavioural and biochemical evidence. | 2008 |
1 |
| 7 |
15813929 | Different responsiveness of striatonigral and striatopallidal neurons to L-DOPA after a subchronic intermittent L-DOPA treatment. | 2005 Mar |
5 |